PMID- 28693371
OWN - NLM
STAT- MEDLINE
DCOM- 20180420
LR  - 20181021
IS  - 1461-7285 (Electronic)
IS  - 0269-8811 (Linking)
VI  - 31
IP  - 8
DP  - 2017 Aug
TI  - Who is 'Molly'? MDMA adulterants by product name and the impact of harm-reduction 
      services at raves.
PG  - 1056-1060
LID - 10.1177/0269881117715596 [doi]
AB  - Methylenedioxymethamphetamine (MDMA), often sold as 'Ecstasy' or 'Molly', is 
      commonly used at music festivals and reported to be responsible for an increase 
      in deaths over the last decade. Ecstasy is often adulterated and contains 
      compounds that increase morbidity and mortality. While users and clinicians 
      commonly assume that products sold as Molly are less-adulterated MDMA products, 
      this has not been tested. Additionally, while pill-testing services are sometimes 
      available at raves, the assumption that these services decrease risky drug use 
      has not been studied. This study analyzed data collected by the pill-testing 
      organization, DanceSafe, from events across the United States from 2010 to 2015. 
      Colorimetric reagent assays identified MDMA in only 60% of the 529 samples 
      collected. No significant difference in the percentage of samples testing 
      positive for MDMA was determined between Ecstasy and Molly. Individuals were 
      significantly less likely to report intent to use a product if testing did not 
      identify MDMA (relative risk (RR) = 0.56, p = 0.01). Results suggest that Molly 
      is not a less-adulterated substance, and that pill-testing services are a 
      legitimate harm-reduction service that decreases intent to consume potentially 
      dangerous substances and may warrant consideration by legislators for legal 
      protection. Future research should further examine the direct effects of 
      pill-testing services and include more extensive pill-testing methods.
FAU - Saleemi, Sarah
AU  - Saleemi S
AD  - 1 Johns Hopkins University School of Medicine, Baltimore, USA.
FAU - Pennybaker, Steven J
AU  - Pennybaker SJ
AD  - 1 Johns Hopkins University School of Medicine, Baltimore, USA.
FAU - Wooldridge, Missi
AU  - Wooldridge M
AD  - 2 Healthy Nightlife, LLC, Denver, USA.
FAU - Johnson, Matthew W
AU  - Johnson MW
AD  - 3 Department of Psychiatry and Behavioral Sciences, Johns Hopkins University 
      School of Medicine, Baltimore, USA.
LA  - eng
PT  - Journal Article
DEP - 20170710
PL  - United States
TA  - J Psychopharmacol
JT  - Journal of psychopharmacology (Oxford, England)
JID - 8907828
RN  - 0 (Pharmaceutical Preparations)
RN  - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine)
SB  - IM
MH  - *Drug Contamination
MH  - *Harm Reduction
MH  - Humans
MH  - N-Methyl-3,4-methylenedioxyamphetamine/*analysis
MH  - Pharmaceutical Preparations/*chemistry
OTO - NOTNLM
OT  - Ecstasy
OT  - MDMA
OT  - Molly
OT  - harm reduction
OT  - pill testing
EDAT- 2017/07/12 06:00
MHDA- 2018/04/21 06:00
CRDT- 2017/07/12 06:00
PHST- 2017/07/12 06:00 [pubmed]
PHST- 2018/04/21 06:00 [medline]
PHST- 2017/07/12 06:00 [entrez]
AID - 10.1177/0269881117715596 [doi]
PST - ppublish
SO  - J Psychopharmacol. 2017 Aug;31(8):1056-1060. doi: 10.1177/0269881117715596. Epub 
      2017 Jul 10.